The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Biodiscovery V, startups are often financed by Astellas Venture Management, Sofinnova Partners, Imperial Innovations. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Takeda Ventures, Sofinnova Partners.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2018. The top amount of exits for fund were in 2018. The fund is generally included in less than 2 deals every year.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Crescendo Biologics, LogicBio Therapeutics. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Health Care.
Related Funds
| Fund Name | Location |
| ACE Investment | China, Foshan, Guangdong |
| All American Properties | - |
| AuronPlay | - |
| Beijing Shiwenhua Chuangyi Chanye Touzi Jijin Guanli Co., Ltd. | Beijing, Beijing, China |
| Digital Health Ventures | Berlin, Berlin, Germany |
| DOCOMO InsightMarketing | Japan, Toshima |
| Fission Capital | China, Hong Kong, Hong Kong Island |
| Gabriel Investments | Pennsylvania, Philadelphia, United States |
| Intercorp Financial Services | Lima, Lima, Peru |
| JiangSu QianRong Assets Management | China, Jiangsu, Suzhou |
| Kalon Venture Partners | Gauteng, Johannesburg, South Africa |
| LANIT Consulting | Columbia, Missouri, United States |
| LMK Ventures | - |
| Magnetik | New York, New York, United States |
| Making Ideas Business | Community of Madrid, Madrid, Spain |
| OPKO Health | Florida, Miami, United States |
| Pioneers Ventures | Austria, Linz, Oberosterreich |
| PoliHub | Italy, Lombardia, Milano |
| Portfolia | California, San Mateo, United States |
| RC Investments | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $70M | 30 Apr 2018 | Cambridge, England, United Kingdom | ||
LogicBio Therapeutics | $45M | 29 Jun 2017 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Crescendo Biologics | $70M | 30 Apr 2018 | Cambridge, England, United Kingdom | ||
LogicBio Therapeutics | $45M | 29 Jun 2017 | California, United States |
